Ahs Hospital Corp.

Ahs Hospital Corp. was paid $125.20M by Medicaid between Jan 2018 and Dec 2024, across 482 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.

33Billing provider infoAHS HOSPITAL CORP.
SUMMIT, NJ 07901

33aNPI1740254143assigned 02/14/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$125.20M

24GClaims2,039,778

24DCodes billed482

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#16 of 93

Median peer was paid$30.60M

This provider vs. median4.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WALTER, JOSEPH controls 12+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	206,443	$14.38M
2019	226,839	$14.45M
2020	185,798	$12.27M
2021	267,708	$17.39M
2022	385,355	$23.49M
2023	439,641	$23.67M
2024incomplete	327,994	$19.55M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	15%	74,761	69,328	$19.18M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	10%	48,536	43,545	$13.01M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.7%	22,940	20,821	$7.20M
G0378	Hospital observation service, per hour	3.3%	11,292	5,340	$4.16M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	3.2%	8,174	7,385	$4.05M
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	2.9%	6,993	2,899	$3.66M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.7%	18,895	18,089	$3.34M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.2%	11,100	10,150	$2.79M
OP710		2.0%	21,624	16,378	$2.50M
96375	Therapeutic injection; each additional sequential IV push	1.9%	26,748	20,243	$2.41M
J9271	Injection, pembrolizumab, 1 mg	1.7%	297	202	$2.18M
0202U	Oncology (prostate), multianalyte, gene expression profiling	1.6%	14,031	13,110	$2.05M

470 more codes

97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.6%	70,598	$2.05M
96361	Intravenous infusion, hydration; each additional hour	1.5%	22,321	$1.89M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.5%	2,159	$1.86M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.4%	17,908	$1.72M
J1439	Injection, ferric carboxymaltose, 1 mg	1.3%	2,169	$1.65M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.3%	9,002	$1.59M
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	1.2%	44,521	$1.54M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.1%	1,583	$1.36M
70450	Computed tomography, head or brain; without contrast material	1.0%	11,358	$1.26M
93017		<1%	4,262	$1.03M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	33,790	$1.01M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	29,377	$983K
OP270		<1%	31,720	$974K
OP250		<1%	212,587	$930K
OP272		<1%	25,609	$875K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,823	$850K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	4,195	$808K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	14,020	$783K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	5,797	$757K
71046	Radiologic examination, chest; 2 views	<1%	19,981	$714K
J2505	Injection, pegfilgrastim, 6 mg	<1%	165	$691K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	8,714	$669K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,898	$655K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	9,476	$651K
62323		<1%	709	$649K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	2,309	$634K
99213	Doctor's office visit, returning patient (routine)	<1%	8,928	$633K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	5,867	$625K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	2,893	$612K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	382	$585K
94060		<1%	2,457	$569K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	364	$568K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	795	$546K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	72,001	$544K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	6,237	$530K
76830	Ultrasound, transvaginal	<1%	4,365	$525K
90834	Psychotherapy session, about 45 minutes	<1%	13,852	$522K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	3,584	$489K
OP370		<1%	3,377	$469K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	21,479	$459K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	978	$446K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	4,296	$439K
80053	Comprehensive metabolic panel	<1%	43,382	$438K
71045	Radiologic examination, chest; single view	<1%	14,549	$425K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,928	$417K
96415		<1%	2,287	$416K
97161		<1%	7,391	$414K
93970		<1%	2,232	$399K
96376		<1%	6,164	$390K
J1756	Injection, iron sucrose, 1 mg	<1%	6,075	$387K
96417		<1%	1,784	$379K
76819	Fetal biophysical profile; without non-stress testing	<1%	3,904	$373K
OP278		<1%	940	$359K
71250		<1%	1,988	$325K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	9,508	$312K
76536		<1%	2,762	$301K
J0897	Injection, denosumab, 1 mg	<1%	225	$299K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	660	$295K
76641		<1%	2,406	$281K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,085	$279K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	340	$273K
99214	Doctor's office visit, returning patient (more involved)	<1%	4,828	$266K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	3,783	$260K
77063	Screening digital breast tomosynthesis, bilateral	<1%	5,288	$258K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,545	$254K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,842	$252K
76801		<1%	3,535	$235K
97162		<1%	3,377	$217K
78815	Positron emission tomography (PET) for limited area imaging	<1%	197	$216K
J1437	Injection, ferric derisomaltose, 10 mg	<1%	132	$212K
92557		<1%	2,033	$207K
76642		<1%	2,376	$206K
93971		<1%	1,945	$202K
70486		<1%	1,209	$187K
96367		<1%	3,201	$183K
74183		<1%	249	$177K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	6,925	$173K
00731		<1%	944	$166K
77065	Tomosynthesis, mammo	<1%	1,541	$159K
76770		<1%	1,272	$158K
73630		<1%	4,408	$157K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	2,524	$157K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	7,992	$152K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	143	$149K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,444	$148K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	5,316	$147K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	8,642	$146K
77066	Tomosynthesis, mammo	<1%	961	$145K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	261	$142K
77080		<1%	1,612	$141K
C1776	Joint device (implantable)	<1%	117	$140K
94726		<1%	1,154	$135K
80047		<1%	26,899	$132K
C9399	Unclassified drugs or biologicals	<1%	1,890	$128K
72197		<1%	166	$125K
00811		<1%	625	$120K
73560		<1%	3,794	$120K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,117	$120K
84484		<1%	18,281	$119K
36415	Collection of venous blood by venipuncture	<1%	74,003	$117K
92588		<1%	1,076	$113K
20610		<1%	173	$113K
93325		<1%	458	$113K
73030		<1%	3,642	$112K
73610		<1%	3,859	$111K
99215	Doctor's office visit, returning patient (complex)	<1%	1,241	$110K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	2,283	$109K
76813		<1%	1,006	$109K
81025		<1%	36,763	$108K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,116	$108K
90791	Psychiatric diagnostic evaluation	<1%	2,603	$106K
86850		<1%	9,573	$104K
47562		<1%	70	$95K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,291	$94K
72100		<1%	2,665	$93K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	289	$91K
87631		<1%	1,428	$90K
12001		<1%	1,002	$86K
93976		<1%	488	$85K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	2,036	$83K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,619	$82K
86900		<1%	10,515	$81K
94010		<1%	618	$81K
73110		<1%	2,289	$80K
74018		<1%	2,333	$80K
90832	Psychotherapy session, about 30 minutes	<1%	2,282	$77K
73130		<1%	2,717	$77K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	3,370	$76K
86901		<1%	10,555	$76K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	3,991	$75K
OP258		<1%	41,439	$72K
00840		<1%	275	$71K
83880		<1%	5,024	$71K
73502		<1%	1,789	$71K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	765	$70K
96416		<1%	344	$70K
59426		<1%	1,602	$68K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	8,024	$66K
72131		<1%	669	$66K
96401		<1%	838	$66K
96411		<1%	239	$65K
88304		<1%	2,136	$64K
87486		<1%	2,894	$63K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	1,300	$63K
88341		<1%	528	$62K
70491		<1%	282	$62K
87428		<1%	3,840	$60K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	3,989	$58K
84443	Thyroid stimulating hormone (TSH)	<1%	5,229	$57K
87581		<1%	2,892	$56K
80048	Basic metabolic panel (calcium, ionized)	<1%	9,867	$55K
94729		<1%	1,178	$55K
93320		<1%	200	$55K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	1,028	$55K
00813		<1%	210	$55K
84702		<1%	5,603	$53K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	6,407	$51K
10060		<1%	591	$51K
97802		<1%	616	$49K
97165		<1%	1,340	$49K
J2704	Injection, propofol, 10 mg	<1%	11,560	$47K
12011		<1%	601	$47K
90715		<1%	2,481	$46K
96523		<1%	766	$46K
72110		<1%	620	$45K
81001		<1%	15,712	$45K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	2,482	$45K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	1,039	$43K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	695	$43K
59425		<1%	1,087	$43K
76857		<1%	678	$43K
99241		<1%	796	$43K
92567		<1%	1,084	$43K
73700		<1%	327	$42K
74021		<1%	1,140	$40K
90472	Immunization administration, each additional vaccine (list separately)	<1%	2,488	$40K
93225		<1%	214	$40K
83690		<1%	12,675	$40K
93226		<1%	187	$40K
76870		<1%	486	$40K
87086	Culture, bacterial; quantitative colony count, urine	<1%	9,084	$39K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,312	$38K
A9585	Injection, gadobutrol, 0.1 ml	<1%	1,191	$38K
72141		<1%	92	$38K
72040		<1%	1,170	$38K
85610		<1%	11,486	$38K
00812		<1%	148	$37K
82962		<1%	12,830	$36K
29125		<1%	958	$36K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	110	$36K
19083		<1%	26	$35K
87040		<1%	3,571	$35K
83605		<1%	4,685	$35K
83735		<1%	9,491	$34K
85730		<1%	9,979	$34K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,328	$33K
64447		<1%	90	$33K
73120		<1%	576	$33K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	384	$33K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	21,836	$32K
71271		<1%	210	$32K
J1453	Injection, fosaprepitant, 1 mg	<1%	874	$31K
77336		<1%	286	$31K
70496		<1%	192	$29K
85027		<1%	6,245	$29K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	109	$29K
0002A		<1%	870	$28K
92550		<1%	1,302	$28K
11045		<1%	206	$28K
81003		<1%	11,964	$27K
C1769	Guide wire	<1%	1,004	$27K
97113		<1%	584	$26K
88342		<1%	995	$26K
36430		<1%	457	$25K
73140		<1%	878	$25K
73562		<1%	809	$25K
84145		<1%	1,967	$25K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	3,103	$25K
73590		<1%	845	$23K
87507		<1%	178	$23K
0001A		<1%	768	$23K
80076		<1%	5,220	$23K
81002		<1%	20,190	$22K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	125	$22K
77334		<1%	38	$22K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	47	$21K
87186		<1%	3,159	$21K
99242		<1%	582	$21K
C2625	Stent, non-coronary, temporary, with delivery system	<1%	39	$21K
H0035	Mental health partial hospitalization, treatment, less than 24 hours	<1%	413	$20K
OP251		<1%	1,353	$19K
73080		<1%	702	$19K
87077		<1%	3,555	$19K
72070		<1%	495	$19K
77011		<1%	89	$19K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	777	$18K
J0690	Injection, cefazolin sodium, 500 mg	<1%	5,418	$17K
99152		<1%	426	$17K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	14,115	$17K
96368		<1%	405	$17K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,131	$16K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	398	$16K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,752	$15K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,990	$15K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	547	$15K
88307		<1%	244	$15K
59025	Fetal non-stress test	<1%	130	$14K
J9190	Injection, fluorouracil, 500 mg	<1%	865	$14K
J1170	Injection, hydromorphone, up to 4 mg	<1%	7,074	$14K
J7050	Infusion, normal saline solution, 250 cc	<1%	7,326	$14K
11043		<1%	61	$14K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	20,699	$14K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	25	$13K
84100		<1%	4,254	$13K
85378		<1%	3,229	$13K
97164		<1%	266	$12K
73090		<1%	426	$12K
76818		<1%	126	$12K
J7030	Infusion, normal saline solution , 1000 cc	<1%	15,137	$12K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	1,391	$12K
80061	Lipid panel	<1%	1,769	$12K
83036	Hemoglobin; glycosylated (A1C)	<1%	3,162	$11K
92579		<1%	78	$11K
0004A		<1%	229	$10K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	619	$10K
92523		<1%	104	$10K
73564		<1%	351	$10K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	4,548	$9K
86140		<1%	3,683	$9K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	107	$9K
77049		<1%	13	$8K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	10,933	$8K
00160		<1%	24	$8K
70498		<1%	50	$8K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	232	$8K
10005		<1%	56	$8K
77002		<1%	144	$8K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	411	$8K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,238	$8K
A4648	Tissue marker, implantable, any type, each	<1%	127	$8K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,630	$8K
82728		<1%	1,156	$7K
72050		<1%	100	$7K
29130		<1%	225	$7K
97803		<1%	166	$7K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	259	$7K
99203	Doctor's office visit, new patient (routine)	<1%	204	$7K
00402		<1%	15	$7K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	302	$7K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	135	$7K
82550		<1%	1,611	$7K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	8,280	$6K
95886		<1%	73	$6K
90674		<1%	357	$6K
90792	Psychiatric diagnostic evaluation with medical services	<1%	147	$6K
36591		<1%	106	$6K
87420		<1%	1,273	$6K
84466		<1%	1,031	$6K
73620		<1%	156	$6K
82077		<1%	1,059	$6K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	29,694	$6K
0071A		<1%	124	$6K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	201	$5K
87070		<1%	844	$5K
95800		<1%	62	$5K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	6,295	$5K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,639	$5K
80143		<1%	859	$5K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	204	$5K
0072A		<1%	114	$5K
90714		<1%	361	$5K
OP255		<1%	1,942	$5K
90686		<1%	2,259	$5K
85652		<1%	2,307	$5K
97014		<1%	787	$5K
90670		<1%	982	$5K
80179		<1%	808	$5K
99153	Mod sedat endo service >5yrs	<1%	84	$5K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	546	$5K
00790		<1%	15	$5K
00920		<1%	12	$5K
71101		<1%	142	$5K
J3370	Injection, vancomycin hcl, 500 mg	<1%	534	$5K
93880		<1%	35	$4K
J1644	Injection, heparin sodium, per 1000 units	<1%	2,999	$4K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	5,165	$4K
90474		<1%	598	$4K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	2,103	$4K
73070		<1%	97	$4K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	680	$4K
77300		<1%	15	$4K
97535	Self-care/home management training, each 15 minutes	<1%	451	$4K
87641		<1%	524	$4K
80320		<1%	75	$4K
64415		<1%	15	$3K
82607		<1%	587	$3K
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	3,566	$3K
J3490	Unclassified drugs	<1%	26,963	$3K
OP279		<1%	644	$3K
84439		<1%	682	$3K
97035		<1%	292	$3K
0064A		<1%	72	$3K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,740	$3K
88173		<1%	191	$3K
59430		<1%	114	$3K
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	909	$3K
82150		<1%	563	$3K
0011A		<1%	80	$3K
76820		<1%	48	$2K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,017	$2K
0012A		<1%	71	$2K
87205		<1%	851	$2K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	395	$2K
87640		<1%	422	$2K
82746		<1%	436	$2K
29515		<1%	67	$2K
74022		<1%	46	$2K
85046		<1%	388	$2K
82803		<1%	174	$2K
72170		<1%	58	$2K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	123	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	253	$2K
83540		<1%	1,033	$2K
86923		<1%	158	$2K
83615		<1%	537	$2K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	586	$2K
85055		<1%	125	$2K
J2060	Injection, lorazepam, 2 mg	<1%	1,539	$1K
82378		<1%	86	$1K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,926	$1K
87430		<1%	259	$1K
0054A		<1%	32	$1K
92587		<1%	12	$1K
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	445	$1K
73060		<1%	50	$1K
J1815	Injection, insulin, per 5 units	<1%	2,404	$1K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	594	$1K
99156		<1%	15	$1K
76000		<1%	15	$995.08
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	126	$948.92
76821		<1%	17	$936.27
C9113	Injection, pantoprazole sodium, per vial	<1%	803	$926.79
86308		<1%	268	$914.36
84156		<1%	226	$896.43
88300		<1%	91	$883.96
86592		<1%	428	$882.80
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	77	$793.40
86803		<1%	86	$761.39
82565		<1%	499	$745.84
J3475	Injection, magnesium sulfate, per 500 mg	<1%	353	$698.36
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	63	$629.13
82553		<1%	88	$624.77
OP259		<1%	87	$620.60
0003A		<1%	20	$614.80
73552		<1%	18	$610.67
90661		<1%	109	$579.72
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	<1%	90	$556.12
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	182	$549.04
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	188	$549.04
00902		<1%	14	$518.06
87076		<1%	104	$504.16
87075		<1%	67	$495.91
99381		<1%	12	$478.14
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	285	$468.07
J7120	Ringers lactate infusion, up to 1000 cc	<1%	28	$438.62
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	322	$438.00
82272		<1%	90	$432.57
94760		<1%	15	$423.43
J1630	Injection, haloperidol, up to 5 mg	<1%	453	$417.57
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	285	$390.81
82570		<1%	244	$383.62
90682		<1%	13	$381.72
J9263	Injection, oxaliplatin, 0.5 mg	<1%	37	$376.54
97750		<1%	47	$365.59
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	63	$365.57
90677		<1%	267	$315.94
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	96	$308.34
87081		<1%	62	$295.74
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	149	$292.56
73600		<1%	14	$281.27
90651		<1%	12	$280.61
90680		<1%	247	$276.08
96377		<1%	14	$274.75
97116		<1%	19	$242.96
75571		<1%	103	$238.50
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	114	$238.31
J7510	Prednisolone oral, per 5 mg	<1%	574	$227.70
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	414	$222.99
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	14	$212.55
87340		<1%	29	$203.92
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	550	$195.89
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	251	$186.98
87593		<1%	14	$185.57
90698		<1%	251	$164.85
C7901	Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service	<1%	23	$162.50
86701		<1%	13	$160.20
0124A		<1%	15	$142.20
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	49	$127.72
J1836	Injection, metronidazole, 10 mg	<1%	162	$126.38
J1171	Injection, hydromorphone, 0.1 mg	<1%	104	$126.05
90633		<1%	135	$122.03
86780		<1%	13	$111.20
84703		<1%	16	$98.34
84132		<1%	29	$83.03
C7900	Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service	<1%	18	$82.02
J2470	Injection, pantoprazole sodium, 40 mg	<1%	94	$75.10
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	43	$68.98
86480		<1%	15	$56.83
J0780	Injection, prochlorperazine, up to 10 mg	<1%	49	$47.15
84295		<1%	12	$45.51
86762		<1%	16	$41.20
90647		<1%	126	$39.00
86880		<1%	14	$38.53
85014		<1%	15	$25.61
85018		<1%	15	$24.62
90723		<1%	42	$22.08
90671		<1%	65	$22.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	14	$19.90
90648		<1%	13	$14.31
90681		<1%	284	$14.00
J0280	Injection, aminophyllin, up to 250 mg	<1%	16	$12.36
90632		<1%	13	$7.00
90716		<1%	17	$6.00
J0687	Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg	<1%	193	$5.22
J2305	Injection, nitroglycerin, 5 mg	<1%	16	$3.10
90744		<1%	12	$3.00
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	17	$2.00
90687		0%	22	$0.00
90707		0%	17	$0.00
90697		0%	169	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWALTER, JOSEPH (SVP, CHIEF FINANCIAL OFFICER)

Same official

Other billing entities under WALTER, JOSEPH

Full network →

Provider	Location	Paid
Ahs Hospital Corp.	Morristown, NJ	$155.87M
Ahs Hospital Corp.	Pompton Plains, NJ	$36.23M
Ahs Hospital Corp	Newton, NJ	$33.62M
Ahs Hospital Corp	Hackettstown, NJ	$16.26M
Ahs Hospital Corp.	Morristown, NJ	$5.20M
Ahs Hospital Corp.	Newton, NJ	$4.82M
Ahs Hospital Corp.	Newton, NJ	$1.26M
Ahs Hospital Corp	Morristown, NJ	$171K
Ahs Hospital Corp.	Morristown, NJ	$1K
Ahs Hospital Corp.	Morristown, NJ	$1K
Ahs Hospital Corp.	Morristown, NJ	$708.57
Ahs Hospital Corp	Morristown, NJ	$149.55

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.